While they're not the answer to all of life's problems, pets can assist their human companions with multiple emotional and mental challenges.

XEcom is announcing a new workshop exploring The Crypto Code, a comprehensive program that introduces beginners to the tools, software and training they need to get started in the world of ...

We break down all things Strava, including how best to interpret your performance stats, to KOM and Local Legend lingo busters. Get the most out of the popular multisports app with our ultimate Strava ...

Capcom has revealed a bunch of new details about Monster Hunter Wilds and its upcoming second open beta.

When is the Elden Ring Nightreign beta? The Lands Between beckons us once more for a standalone expansion that introduces a roguelike loop into FromSoftware’s formula. Playtests are the perfect ...

When is the next Monster Hunter Wilds beta? Very soon! The MHWilds OBT allows players to experience a limited portion of the game ahead of launch, including a character creator to put together the ...

Generation Beta, or Gen Beta, the firm said in a research report, is represented by those born between 2025 and 2039. Their parents will be younger millennials and older Gen Zs, and many will live ...

Can’t wait to dive into Elden Ring Nightreign? You’ll be pleased to learn that a network test beta is taking place soon, which will let lucky players try out an early build of the game.

Registration for the Elden Ring Nightreign beta closed on January 20, so currently there is no way to sign up for the network test if you haven't done so already. The Elden Ring Nightreign beta is ...

The official Android 16 release timeline states that Google will release the first three beta builds in January, February, and March. A Googler has revealed the potential release dates for these ...

IRVINE, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, today announced the pricing of its upsized ...

Jan 22 (Reuters) - Insulin delivery device maker Beta Bionics said on Wednesday it was targeting a valuation of as much as $615.9 million in its initial public offering in the United States ...